search
Back to results

Safety and Efficacy Assessment of Using the zLOCK Facet Stabilization System

Primary Purpose

Low Back Pain

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
zLOCK Facet Stabilization System
Sponsored by
ZygoFix
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Back Pain focused on measuring Stabilization, Facet arthritis, Spondylolisthesis, Stenosis

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patient is scheduled for spine surgery with at least one of the following:

    • Degenerative Spondylolisthesis grade 1;
    • Mild to Moderate stenosis;
    • Degeneration of the facets.
  2. When used stand-alone disc height should be maximum 50% of the adjacent disc height.
  3. 18< Age <75
  4. Weight < 100Kg
  5. Signed informed consent form
  6. At least 3 months of unsuccessful conventional treatments

Exclusion Criteria:

  1. Fusion procedure performed or required in more than one motion segment.
  2. Acute or chronic spinal infections.
  3. Osteoporosis when used in adjunct to an anterior interbody cage (DEXA < -2.5).
  4. Absence of posterior spinal elements including the pedicle, pars interarticularis, facet joints, spinous process and the majority of the lamina which make it unstable or not possible to place.
  5. Any entity or conditions that totally preclude the possibility of fusion, i.e. cancer or kidney dialysis.
  6. Obesity (BMI ≥30)
  7. Unilateral application of device, except in combination with anterior interbody cages.
  8. Known sensitivity to Titanium.
  9. Alcoholism, or drug abuse
  10. Subject with a cardiac pacemaker or other implanted electro medical device
  11. Women who are either pregnant or nursing at the time of screening (to be verified by test in case of woman of child-bearing potential that do not practice medically acceptable methods of contraception)
  12. Concurrent participation in another clinical trial using any investigational drug or device.
  13. Mental disorders.
  14. Tumor
  15. Fracture or other instabilities of the posterior elements.

Sites / Locations

  • MedizinischenFakultät der Universität RostockRecruiting
  • AOU Policlinico "Paolo Giaccone"Recruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

zLock Facet Locking Implant System

Arm Description

Device: zLOCK Facet Stabilization System zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains

Outcomes

Primary Outcome Measures

Incidence of Treatment-Emergent Adverse Events as assessed by paucity of device related reoperation
The safety of the zLOCK Facet Implant System will be established based on the paucity of device-related reoperations.

Secondary Outcome Measures

Change in pain level measured by Visual Analog Score for pain
The efficacy assessment of the ZygoFix Facet stabilization System will be established by change in pain level .

Full Information

First Posted
February 13, 2022
Last Updated
June 29, 2022
Sponsor
ZygoFix
search

1. Study Identification

Unique Protocol Identification Number
NCT05266521
Brief Title
Safety and Efficacy Assessment of Using the zLOCK Facet Stabilization System
Official Title
Safety and Efficacy Assessment of Using the zLOCK Facet Stabilization System
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 7, 2021 (Actual)
Primary Completion Date
January 30, 2023 (Anticipated)
Study Completion Date
September 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ZygoFix

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The zLOCK Facet Stabilization System is a fixation device intended to provide posterior stability in the lumbar spine fusion procedure. The system can be placed either as an adjunct to an inter-vertebral anterior cage or as stand-alone with/ without additional decompression of the dural sac or nerve roots as appropriate for the specific patient and surgeon's discretion. The zLOCK implant is placed inside the facet to stabilize the motion and enhance the bony fusion of the joint. The zLOCK Facet Stabilization System is intended for single-level stabilization of a spinal motion segment in order to promote bony fusion of the joint. The zLOCK system is indicated for use from L1-L2 to L5-S1 joints. The zLOCK implant is inserted into the facet joint space while adapting to the joint's changing geometry. Stabilization is achieved by a firm grip of each joint bone and resisting any relative motion. The zLOCK implant is placed percutaneously and requires only one incision per side, thereby reducing the invasiveness procedure duration and shortening the recovery period. This pivotal study was designed in order to assess the safety and effectiveness of the zLOCK system.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain
Keywords
Stabilization, Facet arthritis, Spondylolisthesis, Stenosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
zLock Facet Locking Implant System
Arm Type
Experimental
Arm Description
Device: zLOCK Facet Stabilization System zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains
Intervention Type
Device
Intervention Name(s)
zLOCK Facet Stabilization System
Intervention Description
zLOCK Facet Stabilization System is a device intended to provide posterior stability in lumbar spine in order to reduce lumbar back pains
Primary Outcome Measure Information:
Title
Incidence of Treatment-Emergent Adverse Events as assessed by paucity of device related reoperation
Description
The safety of the zLOCK Facet Implant System will be established based on the paucity of device-related reoperations.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Change in pain level measured by Visual Analog Score for pain
Description
The efficacy assessment of the ZygoFix Facet stabilization System will be established by change in pain level .
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient is scheduled for spine surgery with at least one of the following: Degenerative Spondylolisthesis grade 1; Mild to Moderate stenosis; Degeneration of the facets. When used stand-alone disc height should be maximum 50% of the adjacent disc height. 18< Age <75 Weight < 100Kg Signed informed consent form At least 3 months of unsuccessful conventional treatments Exclusion Criteria: Fusion procedure performed or required in more than one motion segment. Acute or chronic spinal infections. Osteoporosis when used in adjunct to an anterior interbody cage (DEXA < -2.5). Absence of posterior spinal elements including the pedicle, pars interarticularis, facet joints, spinous process and the majority of the lamina which make it unstable or not possible to place. Any entity or conditions that totally preclude the possibility of fusion, i.e. cancer or kidney dialysis. Obesity (BMI ≥30) Unilateral application of device, except in combination with anterior interbody cages. Known sensitivity to Titanium. Alcoholism, or drug abuse Subject with a cardiac pacemaker or other implanted electro medical device Women who are either pregnant or nursing at the time of screening (to be verified by test in case of woman of child-bearing potential that do not practice medically acceptable methods of contraception) Concurrent participation in another clinical trial using any investigational drug or device. Mental disorders. Tumor Fracture or other instabilities of the posterior elements.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hanna Levy, Dr.
Phone
+972522824966
Email
hanna@qsitemed.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hanna Levy, Dr.
Organizational Affiliation
ZygoFix
Official's Role
Study Director
Facility Information:
Facility Name
MedizinischenFakultät der Universität Rostock
City
Rostock
ZIP/Postal Code
18055
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hanna Levy, Dr.
Phone
+972522824966
Email
hanna@qsitemed.com
Facility Name
AOU Policlinico "Paolo Giaccone"
City
Palermo
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fabio Torregrossa, M.D.
Email
giovanni.grasso@unipa.it
First Name & Middle Initial & Last Name & Degree
Giovanni Grasso, Prof.

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Safety and Efficacy Assessment of Using the zLOCK Facet Stabilization System

We'll reach out to this number within 24 hrs